{{ currentBoardShortName }}

{{data.symbol | reutersRICLabelFormat:group.RICS}}

{{data.netChng | number: 4 }}

{{data.netChng | number: 2 }}

{{data | displayCurrencySymbol}} {{data.price | number: 4 }}

{{data.price | number: 2 }}

{{data.symbol | reutersRICLabelFormat:group.RICS}}

{{data.netChng | number: 4 }}

{{data.netChng | number: 2 }}

{{data | displayCurrencySymbol}} {{data.price | number: 4 }}

{{data.price | number: 2 }}

Markets

As of: {{timeStamp.date}}
{{timeStamp.time}}

{{data.symbol | reutersRICLabelFormat:group.RICS}}

{{data.netChng | number: 4 }}

{{data.netChng | number: 2 }}

{{data | displayCurrencySymbol}} {{data.price | number: 4 }}

{{data.price | number: 2 }}

{{data.symbol | reutersRICLabelFormat:group.RICS}}

{{data.netChng | number: 4 }}

{{data.netChng | number: 2 }}

{{data | displayCurrencySymbol}} {{data.price | number: 4 }}

{{data.price | number: 2 }}

{{ stock.symbol }} {{ stock.price | currency }} {{ stock | formatPrefix }}{{ stock.netChng | formatNetChange }}

Bloomberg News Wire

Latest from Bloomberg

{{ currentStream.Name }}

Related Video

Up Next

Now Showing

{{ video.Name }}

Continuous Play:

The information you requested is not available at this time, please check back again soon.

Nov 30, 2021

Inside the 10-Month Sprint to Develop a Covid Vaccine

Naomi Kresge, Bloomberg News

A health worker prepares a booster dose of the Pfizer-BioNTech Covid-19 vaccine at Ichilov medical center in Tel Aviv, Israel, on Monday, Aug. 2, 2021. Israel is now giving seniors a booster dose of vaccine to help control the recent uptick in cases. Photographer: Kobi Wolf/Bloomberg

A health worker prepares a booster dose of the Pfizer-BioNTech Covid-19 vaccine at Ichilov medical center in Tel Aviv, Israel, on Monday, Aug. 2, 2021. Israel is now giving seniors a booster dose of vaccine to help control the recent uptick in cases. Photographer: Kobi Wolf/Bloomberg , Bloomberg

(Bloomberg) -- Subscribe to Prognosis (Spotify) Subscribe to Prognosis (Apple Podcasts)

Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.

©2021 Bloomberg L.P.